Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Clinical trial NCT05933499 · RECRUITING
Trial details
- NCT number
- NCT05933499
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2028-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.